首页> 外国专利> Proteins specific to pancreatic beta cells on islets of Langerhans and their applications

Proteins specific to pancreatic beta cells on islets of Langerhans and their applications

机译:朗格罕氏胰岛胰β细胞特异的蛋白质及其应用

摘要

Isolated nucleic acid (I) comprises, or correspond to, a 1110 bp human sequence (1), reproduced, or its derivatives. Isolated nucleic acid (I) comprises, or correspond to: (i) a 1110 bp human sequence (1); (ii) a fragment of (1) containing at least 15 consecutive nucleotides (nt) other than the expressed sequence tags GenBank BM565129, BM310003, BM875526, BG655918, BQ417284, BQ267316, BU072134, BQ267526, BQ270198, BU581447, BU070173 and BQ631692; (iii) a sequence at least 80% identical with (i) or (ii), after optimal alignment; (iv) a sequence that hybridizes under stringent conditions with (i) or (ii); or (v) the complement, sense or antisense, of (i)-(iv). Independent claims are also included for: (1) probes for detecting, identifying or determining the corresponding nucleic acid in other organisms consisting of (I); (2) primers for amplification of the corresponding nucleic acid in other organisms consisting of (I); (3) polynucleotide (Ia) obtained by amplification with the primers of (2); (4) determining the transcription profile, or alteration in this, of the gene corresponding to (I); (5) method for detecting the gene corresponding to (I), its allelic variants and functional alterations in it; (6) reagent kit for methods (4) and (5); (7) DNA chip comprising at least one (I); (8) isolated protein (II) having a 369 amino acid sequence (2), reproduced, its analogs, fragments and variants, or any protein encoded by (I); (9) protein chip containing at least one (II); (10) cloning and/or expression vector containing (I); (11) cell transformed by at least one (I) or the vector of (10); (12) non-human transgenic organism in which at least some cells contain (I) or the vector of (10), in free or integrated form; (13) preparing (II) by culturing cells of (11) or organisms of (12); (14) protein (IIa) produced by method (13); (15) mono- or poly-clonal antibodies (Ab) that recognize (II) or (IIa) specifically; (16) protein chip containing at least one Ab; (17) kit for performing method (17); (18) selecting beta -cells of the islets of Langerhans using Ab; (19) monitoring differentiation of stem cells into pancreatic islet cells and beta -cells, using Ab; and (20) screening for (bio)chemicals that interact, in vitro or in vivo, directly or indirectly, with (I), (Ia), (II) or (IIa). ACTIVITY : Antidiabetic. No details of tests for antidiabetic activity are given. MECHANISM OF ACTION : Modulating activity or expression of the zinc transporter ZnT-8, implicated in maturation and exocytosis of insulin.
机译:分离的核酸(I)包含或对应于1110bp的人序列(1),经复制的或其衍生物。分离的核酸(I)包含或对应于:(i)1110bp的人序列(1); (ii)(1)的片段,其含有除表达的序列标签GenBank BM565129,BM310003,BM875526,BG655918,BQ417284,BQ267316,BU072134,BQ267526,BQ270198,BU581447,BU070173和BQ631692以外的至少15个连续核苷酸(nt); (iii)在最佳比对后,与(i)或(ii)至少80%相同的序列; (iv)在严格条件下与(i)或(ii)杂交的序列; (v)(i)-(iv)的互补,有义或反义。还包括以下方面的独立权利要求:(1)用于检测,鉴定或确定由(I)组成的其他生物体中的相应核酸的探针; (2)用于在由(I)组成的其他生物中扩增相应核酸的引物; (3)用(2)的引物扩增得到的多核苷酸(Ia); (4)确定对应于(I)的基因的转录图谱或其中的改变; (5)检测与(I)相对应的基因,其等位基因变体和功能改变的方法; (6)方法(4)和(5)的试剂盒; (7)DNA芯片,其包含至少一个(I); (8)复制的具有369个氨基酸序列(2)的分离的蛋白质(II),其类似物,片段和变体或由(I)编码的任何蛋白质; (9)含有至少一种(II)的蛋白质芯片; (10)含有(I)的克隆和/或表达载体; (11)被至少一个(I)或(10)的载体转化的细胞; (12)非人类转基因生物,其中至少一些细胞含有游离或整合形式的(I)或(10)的载体; (13)通过培养(11)的细胞或(12)的生物来制备(II); (14)通过方法(13)产生的蛋白质(IIa); (15)特异性识别(II)或(IIa)的单克隆或多克隆抗体(Ab); (16)含有至少一种抗体的蛋白质芯片; (17)用于执行方法(17)的套件; (18)使用Ab选择朗格汉斯岛的β-细胞; (19)使用Ab监测干细胞向胰腺胰岛细胞和β细胞的分化。 (20)筛选与(I),(Ia),(II)或(IIa)在体外或体内直接或间接相互作用的(生物)化学物质。活动:抗糖尿病。没有给出抗糖尿病活性测试的细节。作用机理:调节锌转运蛋白ZnT-8的活性或表达,与胰岛素的成熟和胞吐有关。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号